Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Salzmann Peter Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2023 4 Salzmann Peter (CEO) has filed a Form 4 on Immunovant, Inc.
Txns: Sold 894 shares @ $35.54, valued at $31.8k
Sold 4,345 shares @ $36.39, valued at $158.1k
08/16/2023 4 Salzmann Peter (CEO) has filed a Form 4 on Immunovant, Inc.
Txns: Sold 91,744 shares @ $21.34, valued at $2M
Sold 11,314 shares @ $22.04, valued at $249.4k
08/08/2023 4 Salzmann Peter (CEO) has filed a Form 4 on Immunovant, Inc.
Txns: Sold 101,339 shares @ $21.73, valued at $2.2M
07/13/2023 4 Salzmann Peter (CEO) has filed a Form 4 on Immunovant, Inc.
Txns: Sold 3,233 shares @ $19.73, valued at $63.8k
04/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/14/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/13/2023 4 Salzmann Peter (CEO) has filed a Form 4 on Immunovant, Inc.
Txns: Sold 4,021 shares @ $16.8, valued at $67.6k
10/17/2022 4 Salzmann Peter (CEO) has filed a Form 4 on Immunovant, Inc.
Txns: Sold 2,793 shares @ $9.18, valued at $25.6k
09/29/2022 4 Salzmann Peter (CEO) has filed a Form 4 on Immunovant, Inc.
Txns: Sold 1,605 shares @ $4.67, valued at $7.5k
09/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/29/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/25/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/29/2022 4 Salzmann Peter (CEO) has filed a Form 4 on Immunovant, Inc.
Txns: Sold 1,622 shares @ $4.72, valued at $7.7k
04/14/2022 4 Salzmann Peter (CEO) has filed a Form 4 on Immunovant, Inc.
Txns: Sold 19,227 shares @ $5.9, valued at $113.4k
01/11/2022 4 Salzmann Peter (CEO) has filed a Form 4 on Immunovant, Inc.
Txns: Sold 125,158 shares @ $7.25, valued at $907.4k
09/14/2021 4 Salzmann Peter (CEO) has filed a Form 4 on Immunovant, Inc.
Txns: Granted 430,700 options to buy @ $8.62, valued at $3.7M
Disposed/sold 430,700 options to buy @ $19.01, valued at $8.2M
Granted 464,700 options to buy @ $8.62, valued at $4M
Disposed/sold 464,700 options to buy @ $17, valued at $7.9M
06/17/2021 4 Salzmann Peter (Director) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.
Txns: Granted 58,200 options to buy @ $2.07, valued at $120.5k
03/23/2021 4 Salzmann Peter (CEO) has filed a Form 4 on Immunovant, Inc.
Txns: Granted 132,500 shares @ $0
Granted 464,700 options to buy @ $17, valued at $7.9M
05/22/2020 4 Salzmann Peter (Director) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.
Txns: Granted 40,500 options to buy @ $7.3, valued at $295.7k
05/18/2020 4 Salzmann Peter (CEO) has filed a Form 4 on Immunovant, Inc.
Txns: Granted 430,700 options to buy @ $19.01, valued at $8.2M
03/10/2020 4 Salzmann Peter (Director) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.
Txns: Granted 66,600 options to buy @ $4.53, valued at $301.7k
12/20/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy